Search company, investor...

About Alnion

Alnion’s product is low cost, non-invasive diagnostic appliance capable of early stage lung cancer detection. Novel tools are required to address raising costs of lung cancer screening, treatment and the high false positives (96%) of current invasive tools. Our advanced e-nose technology offers solutions to all of these current shortcomings through highly sensitive and patented CNT technology by detecting patterns of VOCs in human breath, thus identifying lung cancer and it’s sub-histologies.

Headquarters Location

Loading...

Loading...

Alnion Frequently Asked Questions (FAQ)

    Loading...

    Loading...

    CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.